Research Topics
| D M SkowronskiSummaryAffiliation: British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactionsDanuta M Skowronski
Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, Canada
PLoS ONE 8:e54015. 2013..However risk assessment may change with time and depends crucially upon the validation of epidemiological features of influenza, notably the serologic correlate of protection and R(0)...
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)Danuta M Skowronski
British Columbia Centre for Disease Control, Canada
J Infect Dis 206:1852-61. 2012..We estimate levels of cross-reactive antibody to H3N2v by age and assess whether seasonal trivalent inactivated influenza vaccine (TIV), with or without adjuvant, may increase seroprotection...
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 seasonDanuta M Skowronski
British Columbia Centre for Disease Control, Provincial Health Services Authority, Vancouver, Canada
Clin Infect Dis 55:332-42. 2012..Interim analysis from the community-based sentinel surveillance system showed circulating H3N2 variants and suboptimal vaccine effectiveness (VE), assessed here for the entire season's data set...
Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominanceDanuta M Skowronski
Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
PLoS ONE 7:e38929. 2012....
Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everythingJessica M Conway
Division of Mathematical Modeling, University of British Columbia Centre for Disease Control, 655 West 12th Avenue, V5Z 4R4 Vancouver, British Columbia, Canada
BMC Public Health 11:932. 2011..We adapted a city-level contact network model to study different campaigns on influenza morbidity and mortality...
The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunizationDanuta M Skowronski
Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control BCCDC, Vancouver Canada
Clin Infect Dis 54:318-27. 2012..We illustrate the high number needed to vaccinate (NNV) for this program based on recent epidemiologic data from the provinces of Québec and British Columbia (BC), Canada...
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in CanadaD M Skowronski
Epidemiology Services, BC Centre for Disease Control, Canada
Vaccine 25:2842-51. 2007....
Solicited adverse events after influenza immunization among infants, toddlers, and their household contactsDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Pediatrics 117:1963-71. 2006..We assessed adverse events, including oculorespiratory syndrome, following influenza immunization during the first year of a publicly-funded program for infants, toddlers and their household members in Canada...
Coordinated response to SARS, Vancouver, CanadaDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Emerg Infect Dis 12:155-8. 2006..Baseline preparedness for pandemic threats may account for the absence of sustained transmission and fewer cases of SARS in Vancouver...
Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from CanadaDanuta M Skowronski
University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4
Vaccine 24:4222-32. 2006..We assess cost-effectiveness of this program in Canada...
Oculorespiratory syndrome after influenza immunization in childrenDanuta M Skowronski
Epidemiology Services, UBC Centre for Disease Control, 655 West 12t Avenue, Vancouver, BC, Canada V5Z 4R4
Pediatr Infect Dis J 24:63-9. 2005..ORS included bilateral red eyes, facial edema or respiratory symptoms beginning within 24 hours of influenza immunization. Few reports involved children. We assessed the rate of ORS in a pediatric cohort...
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007Danuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
J Infect Dis 199:168-79. 2009..We describe a sentinel surveillance approach to link influenza variant detection with component-specific vaccine effectiveness (VE) estimation...
Is routine influenza immunization warranted in early pregnancy?Danuta M Skowronski
BC Centre for Disease Control, Vancouver, BC, Canada
Vaccine 27:4754-70. 2009..Evidence is otherwise insufficient to recommend routine TIV as the standard of practice for all healthy women beginning in early pregnancy...
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from CanadaDanuta M Skowronski
British Columbia Centre for Disease Control BCCDC, Vancouver, British Columbia, Canada
PLoS Med 7:e1000258. 2010..Several epidemiologic investigations were conducted through the summer to assess this putative association...
Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemicDanuta M Skowronski
BC Centre for Disease Control, Vancouver, BC
CMAJ 182:1851-6. 2010..We reassessed this profile of seroprotection by age in the same region six months after the fall 2009 pandemic and vaccination campaign...
Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced ageDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, BC, V5Z 4R4, Canada
J Infect Dis 203:158-67. 2011..Pandemic H1N1 (pH1N1) surveillance data showed lower attack rates but higher risk of severe outcomes with advanced age. We explored immuno-epidemiologic correlates of surveillance findings including humoral and cell-mediated immunity (CMI)...
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009Danuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, BC, Canada
BMJ 342:c7297. 2011..To assess the effectiveness of the pandemic influenza A/H1N1 vaccine used in Canada during autumn 2009...
Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/YamagataDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Pediatr Infect Dis J 30:833-9. 2011..Trivalent inactivated influenza vaccine (TIV) contains 1 of 2 influenza B/lineages (B/Yamagata or B/Victoria) annually. We assessed prime-boost responses in young children following a change in the B/lineage included in TIV...
Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, CanadaDanuta M Skowronski
BC Centre for Disease Control, Vancouver, BC
CMAJ 176:47-53. 2007..In 2004 an outbreak of avian influenza of the H7N3 subtype occurred among poultry in British Columbia, Canada. We report compliance with recommended protective measures and associated human infections during this outbreak...
Severe acute respiratory syndrome (SARS): a year in reviewDanuta M Skowronski
University of British Columbia Center for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4
Annu Rev Med 56:357-81. 2005..This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise...
Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?Danuta M Skowronski
University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, Canada
Clin Infect Dis 36:705-13. 2003..The surveillance case definition for ORS for 2001-2002 was revised to include onset <or=24 h after vaccination, with no restriction on duration. ORS should be incorporated into annual influenza vaccine safety monitoring...
Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affectedDanuta M Skowronski
Canadian Association for Immunization Research and Evaluation, Vancouver, British Columbia, Canada
Clin Infect Dis 37:1059-66. 2003..Previously affected persons should be informed of the risk of ORS recurrence but also that episodes of such recurrence are mild and well tolerated...
Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impactDanuta M Skowronski
University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Pediatrics 112:e453. 2003....
Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 monthsDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Pediatrics 128:e276-89. 2011..We assessed whether 2 full versus 2 half-doses of trivalent inactivated influenza vaccine (TIV) could improve immunogenicity without increasing reactogenicity in infants (aged 6-11 months) and toddlers (aged 12-23 months)...
Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?Danuta M Skowronski
University of British Columbia Centre for Disease Control, Epidemiology Services, Vancouver, British Columbia, Canada
J Infect Dis 187:495-9. 2003..Although vaccinated ORS-affected individuals had less of a type 1 basis than did vaccinated unaffected individuals, this difference was not statistically significant...
Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and reviewDanuta M Skowronski
British Columbia Centre for Disease Control, St Paul s Hospital and University of British Columbia, Vancouver, British Columbia V5Z 4R4, Canada
Clin Infect Dis 36:e1-4. 2003..Adult booster immunization against pertussis should be considered to protect adults themselves from this illness and its potential complications...
Low risk of recurrence of oculorespiratory syndrome following influenza revaccinationDanuta M Skowronski
UBC Centre for Disease Control, Vancouver, BC
CMAJ 167:853-8. 2002..We examined the risk of recurrence of ORS for individuals affected in 2000-2001 who were revaccinated in the community setting in 2001-2002...
The changing age and seasonal profile of pertussis in CanadaDanuta M Skowronski
University of British Columbia Centre for Disease Control, Epidemiology Services, Vancouver, British Columbia, Canada V5Z 4R4
J Infect Dis 185:1448-53. 2002....
Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptakeDanuta M Skowronski
University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4
Vaccine 23:353-61. 2004..To anticipate adult coverage with a combined product containing tetanus (T) and diphtheria (d) toxoids and acellular pertussis (aP) vaccine as a booster dose, we conducted a survey of households in British Columbia, Canada...
Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 studentsDavid M Patrick
Epidemiology Services, University of British Columbia Centre for Disease Control, Vancouver, Canada
Pediatr Infect Dis J 22:874-7. 2003..This study documents trends in the reported rate of acute HB disease since 1992 and examines factors bearing on the rate of infection throughout the period of program implementation...
Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 seasonDanuta M Skowronski
UBC Centre for Disease Control, 655 West 12th Avenue, Vancouver, British Columbia, Canada V5Z 4R4
Vaccine 20:2713-9. 2002..Skin test reaction size or quality could not identify persons at risk of ORS. Skin testing could not identify a specific strain or the stage in the manufacturing process during which the trigger may have been introduced...
Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004R Sebastian
Epidemiology Services, British Columbia Centre for Disease Control, 655 12th Avenue West, Vancouver, British Columbia, V5Z 4R4 Canada
Vaccine 26:1397-403. 2008..We conclude that the very young and old suffer the greatest morbidity due to P&I, and an indirect role for school-aged children in anticipating the risk to others warrants further evaluation...
Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeksJ A Buxton
British Columbia Centre for Disease Control, University of British Columbia, Vancouver, Canada
J Infect Dis 184:188-91. 2001..Response to B/Harbin was less throughout the study. A/Sydney antibody titer was lower with more times vaccinated in the previous 5 years. Therefore, a second vaccine did not enhance the immune response...
Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adultsDavid W Scheifele
Canadian Association for Immunization Research and Evaluation of Vancouver, British Columbia, Canada
Clin Infect Dis 36:850-7. 2003..We conclude that certain mild oculorespiratory symptoms were triggered by an influenza vaccine that was otherwise minimally reactogenic and, hence, that such symptoms might be associated with influenza vaccines in general...
Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North AmericaBabak Pourbohloul
Division of Mathematical Modeling, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Influenza Other Respi Viruses 3:215-22. 2009..We determined the reproduction number of pandemic (H1N1) 2009 by analyzing the dynamics of the complete case series in Mexico City during this early period...
One arm or two? Concurrent administration of meningococcal C conjugate and hepatitis B vaccines in pre-teensKaren L Pielak
British Columbia Centre for Disease Control, Vancouver, BC
Can J Public Health 99:52-6. 2008....
Novel avian influenza H7N3 strain outbreak, British ColumbiaMartin Hirst
British Columbia Cancer Agency (BCCA) Genome Sciences Centre, Vancouver, British Columbia, Canada
Emerg Infect Dis 10:2192-5. 2004..This insertion likely occurred by recombination between the hemagglutination and matrix genes in the LPAI virus...
Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?Danuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
J Infect Dis 197:490-502. 2008..The historic concern that the influenza vaccine-induced antibody response in the elderly declines more rapidly and below seroprotective levels within 4 months of immunization should be reconsidered...
Human illness from avian influenza H7N3, British ColumbiaS Aleina Tweed
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Emerg Infect Dis 10:2196-9. 2004..Surveillance identified two persons with confirmed avian influenza infection. Symptoms included conjunctivitis and mild influenzalike illness...
Modeling control strategies of respiratory pathogensBabak Pourbohloul
Division of Mathematical Modeling, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Emerg Infect Dis 11:1249-56. 2005..Contact network epidemiology can provide valuable quantitative input to public health decisionmaking, even before a pathogen is well characterized...
A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trialDavid W Scheifele
Canadian Association for Immunization Research and Evaluation CAIRE and the Vaccine Evaluation Center, BC Children s Hospital and the University of British Columbia, Vancouver, British Columbia, Canada
Pediatr Infect Dis J 24:1059-66. 2005..Large injection site reactions commonly follow booster doses of diphtheria-tetanus-acellular pertussis (DTaP) vaccines at 4-6 years of age. A vaccine with lower diphtheria and pertussis dosage (Tdap) might be better tolerated for this dose...
The Genome sequence of the SARS-associated coronavirusMarco A Marra
British Columbia Cancer Agency BCCA Genome Sciences Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada
Science 300:1399-404. 2003....
Disparities in varicella vaccine coverage in the absence of public fundingReka Gustafson
Department of Health Care and Epidemiology, University of British Columbia, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4
Vaccine 23:3519-25. 2005..Among parents of susceptible children, 59% (343/582) would vaccinate their child if it were provided free; 25% (148/582) were undecided...
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirusRaymond H See
University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
J Gen Virol 87:641-50. 2006..Finally, the sera of vaccinated mice contained antibodies to S, further suggesting a role for this protein in conferring protective immunity against SARS-CoV infection...
Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implicationsDavid Scheifele
Canadian Association for Immunization Research and Evaluation, Vancouver, British Columbia, Canada
Control Clin Trials 24:99-104. 2003..Providing a safety valve for inevitable tensions between investigators and sponsor was an understated but significant role. Lessons from our experience will be particularly pertinent to future studies of pandemic influenza vaccines...
Prevalence of hearing loss in primary school children in ZimbabweBrian D Westerberg
Division of Otolaryngology, University of British Columbia, St Paul s Rotary Hearing Clinic, Providence 2, 1081 Burrard St, Vancouver, BC, Canada V6Z 1Y6
Int J Pediatr Otorhinolaryngol 69:517-25. 2005..The objective of the study was to determine the prevalence of significant hearing impairment in children attending primary school in the country of Zimbabwe...
The clinical spectrum of the oculo-respiratory syndrome after influenza vaccinationGaston De Serres
Quebec National Institute of Public Health, Quebec, Que, Canada
Vaccine 21:2354-61. 2003....
Network theory and SARS: predicting outbreak diversityLauren Ancel Meyers
Section of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, 1 University Station C0930, Austin, TX 78712, USA
J Theor Biol 232:71-81. 2005..We offer quantitative insight into the heterogeneity of SARS outbreaks worldwide, and illustrate the utility of this approach for assessing public health strategies...
Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse modelShawn Babiuk
Vaccine and Infectious Disease Organization, Saskatoon, SK, Canada
J Med Virol 72:138-42. 2004..We confirm that vaccine aggregates deviate the immune response to a greater Th2 cytokine pattern with potential implications for vaccine screening, safety, and efficacy...
Identification of severe acute respiratory syndrome in CanadaSusan M Poutanen
Toronto Medical Laboratories and Mount Sinai Hospital Department of Microbiology, Toronto, Canada
N Engl J Med 348:1995-2005. 2003..It appears to be of viral origin, with patterns suggesting droplet or contact transmission. The role of human metapneumovirus, a novel coronavirus, or both requires further investigation...
Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected personsGaston De Serres
Institut National de Sante Publique du Quebec, Quebec, Canada
Arch Intern Med 164:2266-72. 2004..Oculorespiratory syndrome (ORS) after influenza vaccination has many features of an allergic reaction...
Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasonsGaston De Serres
Institut National de Sante Publique du Quebec, Canada
Vaccine 23:3726-32. 2005..Oculo-respiratory syndrome (ORS) following influenza vaccination was identified in Canada in 2000. This report describes trends of ORS reported during four consecutive seasons 2000, 2001, 2002 and 2003 in the province of Quebec, Canada...
Detection of human influenza virus in the stool of childrenSusan H Wootton
Pediatr Infect Dis J 25:1194-5. 2006
Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, CanadaDanuta M Skowronski
J Infect Dis 193:899-900; author reply 900-1. 2006
The cost of preventing rabies at any cost: post-exposure prophylaxis for occult bat contactCaroline Huot
Department of Social and Preventive Medicine, Laval University, Quebec, Canada
Vaccine 26:4446-50. 2008..Household bat exposure has become the most frequent reason for RPEP administration. Given the rarity of rabies, RPEP recommendations related to household bat exposure may warrant review...
Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contactGaston De Serres
Institut National de Sante Publique du Quebec, Canada
Clin Infect Dis 46:1329-37. 2008..Since the 1980s, rare cases of rabies in humans in Canada and the United States have been almost exclusively caused by the bat-variant virus...
